DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Wilcox MH, Gerding DN, Poxton IR. et al.
Bezlotoxumab for Prevention of Recurrent Clostridium difficile. Infection.
N Engl J Med 2017;
376: 305-317
We do not assume any responsibility for the contents of the web pages of other providers.